Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
8.75
+0.63 (7.76%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sagimet Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 285 | 193 | 145 | 124 | - | - | |
| Market Cap Growth | 297.13% | 32.89% | 16.75% | - | - | - | |
| Enterprise Value | 172 | 67 | -25 | 22 | - | - | |
| Last Close Price | 8.75 | 5.92 | 4.50 | 5.42 | - | - | |
| PS Ratio | - | - | - | 62.05 | - | - | |
| PB Ratio | 2.55 | 1.73 | 0.93 | 1.36 | - | - | |
| P/TBV Ratio | 2.56 | 1.73 | 0.93 | 1.36 | - | - | |
| EV/Sales Ratio | - | - | - | 11.18 | - | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.02 | -1.04 | -1.16 | -1.00 | |
| Asset Turnover | - | - | - | 0.03 | - | - | |
| Quick Ratio | 22.18 | 22.18 | 33.96 | 16.78 | 6.13 | 23.25 | |
| Current Ratio | 22.82 | 22.82 | 34.30 | 17.09 | 6.21 | 24.04 | |
| Return on Equity (ROE) | -38.20% | -38.20% | -36.92% | -46.96% | -72.58% | -39.63% | |
| Return on Assets (ROA) | -25.70% | -25.70% | -26.49% | -29.62% | -42.16% | -23.16% | |
| Return on Capital Employed (ROCE) | -51.10% | -51.10% | -35.00% | -33.80% | -111.90% | -41.90% | |
| Earnings Yield | -17.90% | -26.51% | -31.45% | -22.46% | - | - | |
| Buyback Yield / Dilution | -3.17% | -3.17% | -199.71% | -5565.90% | -50.61% | -26.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.